Click here for Video testimonials Please dont't forget to save this website to your favourites before you leave it. :-)

NADH Internal Power......Anti-Aging World Patent

NADH the Energising Co-enzyme

NADH is the biological Rocket Fuel.. It is the biological form of hydrogen which reacts with the oxygen present in our cells to produce energy... The more NADH we have the more energy we can produce

NADH is good for Fibromyaliga, ME, CFS, PARKINSONS, ALZHEIMERS and much much more..

NADH 10mg & 20MG Quick acting Lozenger is excellent for Sports.. It Boosts ATP (Cellular) Energy and Cognitive Performance...Helps Drowsiness for Long Journeys etc. Exams.. Jet Lag, Time Zone changes, boost Stamina and

Endurance, Restoring Alertness and Energy

THE ONLY NADH PRODUCT MADE FROM "FOOD GRADE" NADH RAW MATERIAL!!!!! Trust only "CO-E1 NADH"!!!

ALSO KNOWN AS CO-E1 ENADA , ENADA NADH, MOJO ENADA.
NADH is an excellent energy supplement that plays a key role in the energy production of cells, particularly in the brain and central nervous system. The more NADH a cell has available, the more energy it can produce to perform its processes efficiently.

NADH
NADH stimulates cellular production of the neurotransmitters Dopamine, Noradrenaline, and Serotonin, thereby improving mental clarity, alertness, and concentration. NADH is involved in over 1,000 metabolic actions in the body!!!!!!
NADH is directly involved in the body's cellular immune defensive system and the more NADH in your body the better the DNA repair system functions.
NADH, biologically known as Coenzyme 1 (as it is the most important co-enzyme, also known as Co-E1 ), is the reduced form of nicotinamide adenine dinucleotide (NAD) with high energy hydrogen (H) which provides energy to the cell. NADH is necessary for thousands of biochemical reactions within the body and is found naturally in every living cell.
If you want to stay healthy and vital, you will want to absorb sufficient amounts of hydrogen. Hydrogen in its biologically active form—the negatively charged hydrogen anion—is what gives energy to your body cells, activating cell metabolism and optimal cell regeneration. Furthermore, negatively charged hydrogen with its extra electron is a highly efficient antioxidant which is able to neutralize free radicals in your body and thus protects against many illnesses that were previously regarded as due to age.

In the organism, NADH or Coenzyme 1 is the natural biological carrier of H-minus.

NADH has also been known as the dietary supplement ENADA , used to help boost energy and add vitality to your life. We our proud to offer you this product, now branded as Co-E1 NADH. This is the same formula that will make a difference in your day to day activities and may also aid in combating the effects of disorders such as fibromyalgia .
Birkmayer Health Products are also proud to be able to provide you with a new product, co-e1 enada 10mg , mojo enada 20mg. the quick-acting, fast-dissolving lozenge form of stabilized NADH. If you go through your day feeling like you need that extra boost of energy or a kick start in your ATP production, then this is the energy pill for you. Like Co-E1 NADH this may be used to alleviate the symptoms of certain energetic disorders such as chronic fatigue .

ENADH NADH
ENADH is the world's first and only NADH dietary supplement that is now available to everyone whose lifestyle demands more energy, vitality, and mental activity.

NADH, biologically known as Co-Enzyme 1 (or Co-E1 , an extremely important enzyme in energy production), is the reduced form of nicotinamide adenine dinucleotide (NAD) with high energy hydrogen (H) which provides energy to the cell. NADH is necessary for thousands of biochemical reactions within the body and is found nturally in every living cell.

NADH is a Co-Enzyme naturally present in ALL living cells and is NECESSARY for Cellular development and Energy production.

NADH is NOT a HORMONE and is NOT a STEROID.

NADH is an energy supplement and potent ANTIOXIDANT form of Vitamin B3. Moreover, NADH also helps form antioxidants in your body. Specifically, a molecule called CoQ10 (also known as Co-enzyme Q-10) is reduced by NADH, thus making this coenzyme an antioxidant. Antioxidants have several benefits, one of the most important of which is the reduction of cancer-causing free radicals.

NADH plays a key role in the energy production of cells, particularly in the brain and central nervous system, making it an effective energy pill . The more NADH a cell has available, the more energy it can produce to perform its process efficiently. Individuals who suffer from disorders such as chronic fatigue , or individuals who simply need a boost in the energy levels, can benefit from Co-E1 NADH supplements .

NADH stimulates cellular production of the neurotransmitters Dopamine, Noradrenaline, and Serotonin, thereby improving mental clarity, alertness and concentration.

NADH is directly involved in the body's cellular immune defensive system. The more NADH in your body the better the DNA repair system functions.

NADH is clinically proven effective for Chronic Fatigue Syndrome. CFS patients taking NADH are 4 times more likely to IMPROVE than those taking a placebo fatigue vitamin.

ENADAlert now known as 10mg & 20mg nadh (enada) ® is an alternative approach that counters the effects of jet lag and fatigue by providing the traveler with the additional energy and alertness needed to alleviate their symptoms. ENADAlert® provides this energy in the form of the energy-producing coenzyme NADH (ß-nicotinamide adenine dinucleotide hydrogen) also known as the reduced form of Coenzyme 1.

NADH is a naturally-occurring substance that is present in all the cells in your body. It is not a stimulant or a sedative, so it won't leave you nervous and jittery like caffeine. An energy pill containing NADH has been demonstrated to increase cellular production of ATP, the natural energy storage compound in the body. NADH supplements can therefore help you feel more energetic and alert.

ENADAlert® is not a replacement for sleep; it is a fatigue medication that helps relieve drowsiness, restores alertness and energy, and boosts stamina and endurance – naturally.

Enadalert NADH the Nutritional Supplement Clinically Tested* for Jet Lag

Helps Relieve the Tiredness, Sleepiness & Cognitive Drowsiness Associated with Jet Lag & Long Distance Travel.

Dr. Gary Kay from the Washington Neuropsychological Institute and Georgetown University Medical Center stated in a double blind clinical trial that "Stabilized NADH (ENADAlert®) was found to significantly reduce the cognitive effects and sleepiness induced by jet lag. The group taking ENADAlert®, reported relief from the effects of jet lag after the cross country 'red eye' flight." The study team stated that, "we feel our results clearly demonstrate that ENADAlert is effective as a countermeasure for jet lag."

Study findings were presented at the
48th International Congress of Aviation and Space Medicine, September, 2000.
*Stabilized NADH as a Countermeasure for Jet Lag

NADH Supplements, Energy Pills, & More...
NADH supplements can also improve symptoms of individuals suffering from other fatigue-related maladies. In addition to jet lag, many who have taken Co-E1 or ENADAlert have found improved vitality and energy with disorders such as chronic fatigue.

CO-E1 NADH 10mg & 20mg Lozenges for SPORTS
Energy Increase
Increase ATP levels
Biological Rocket Fuel
Energizes Mental & Physical
Increases ATP heart energy
Increases Intracellular Energy in Athletes
The Most Important Functions of CO-E1 NADH lozenges are:-
Production of ATP (cellular) Energy.
Supply of Instant Energy for the Body and Brain.
Extending longevity of the Life Span of Cells; Tissues and Organs
Strong Anti-oxidant properties.
Protection of the Heart
Improved Libido
Boosts Immune System.
Why the 10mg Fast Action/Lozenge "CO-E1 NADH " ???
It is the new quick acting fast dissolving lozenge form of stabilized NADH.
Complies with today's modern fast living lifestyle.
The lozenge application is in use by the body and the brain within 10 minutes.
Enadalert has a faster absorption rate due to the uptake via the oral mucosa.
Is very applicable and easily administered for/by athletes.

PARKINSONS & NADH
Recent studies have shown that Co-E1 can help alleviate the symptoms of Parkinson 's disease. Parkinson's disease is a neurological disorder in which specific neurons required for coordinated movement begin to atrophy and die. These brain cells are responsible for the production of dopamine. The lack of dopamine is ultimately what results in Parkinson's symptoms, but ENADA can help.

The Birkmayer Institute for Parkinson's Therapy has demonstrated a therapeutic link between Parkinsons and NADH . To simplify, the NADH coenzyme is required in the biochemical pathway of dopamine. Thus, increasing NADH in the body can also increase dopamine production, which substitutes what the atrophied neurons used to do. With increased dopamine, the Parkinson's disease symptoms will be lessened.

Individuals have also taken ENADH to help with symptoms of other disorders. Since our product has multiple benefits, including energy production, it may be used to improve the lives of those who suffer from fatigue-related ailments such as fibromyalgia

Dr. Georg Birkmayer
Professor Georg Birkmayer, M.D., Ph.D., developer of ENADA ® and ENADAlert® stabilized NADH, was the first to identify the importance of NADH in cellular development and energy transmissions for all bodily functions and organs. He founded Menuco Corporation in 1995 and is a world-renowned biochemical researcher and Medical Director of the Birkmayer Institute for Parkinson's Therapy, which has treated thousands of patients suffering from Parkinson's disease after having studied the biochemical connections between Parkinsons and NADH .

Additionally, Dr George Birkmayer is a Professor at the University of Graz, Austria and head of its Division of Neurochemistry at the Department of Medical Chemistry. He is also visiting professor at the University of Beijing and Canton , China and Secretary General of the International Academy of Tumor Marker Oncology in New York . He is the European Editor of the Journal of Tumor Market Oncology, and a member of the editorial board of the Journal of Experimental and Clinical Cancer Research as well as additional scientific journals. He is a member of several international scientific societies including the New Academy of Sciences and the American Association of Cancer Research. He is also a Fellow of the American College of Nutrition.

The Menuco Corporation is proud to be a leading supplier of ENADA NADH supplements and energy pills. The newly branded Co-E1 NADH dietary supplement can help individuals suffering from chronic fatigue disorders, energy deficiencies, as well as other ailments such as diabetes and neurological disorders. Athletes, mature individuals, or anybody needing a boost in energy or alertness may benefit from these NADH supplements . Menuco Corporation also manufactures the easily digestible ENADAlert Now known as Co-E1 NADH quick acting nadh in 10 & 20mg supplement,

American College of Allergy, Asthma & Immunology (ACAAI) o 85 W. Algonquin Road, Suite 550, Arlington Heights, IL 60005

New Diagnostic Tool
ENADA - A Nutritional Supplement for Healthy Individuals Desiring More Natural Energy
NUTRITIONAL SUPPLEMENT OFFERS RELIEF FOR CHRONIC FATIGUE SYNDROME (CFS)
Doctor: Parker (Jensen) 'a healthy boy,' thanks to pills !!!

Download PDF

Doctor touts using NADH for much more than cancer treatment.

Download PDF

Co-E1 NADH (formerly known by the name brand ENADA NADH ) is an amazing dietary supplement that has an abundance of beneficial effects on a cellular level. Many individuals take Co-E1 NADH as an energy pill because it can effectively increase ATP production. ATP, or adenosine triphosphate, is the primary energy carrier of the body. Increasing the production of this molecule can offset the symptoms of certain disorders such as chronic fatigue disability . Please do some research and read some of the articles below to see how this supplement can be used as a fatigue medication.

American College of Allergy, Asthma & Immunology (ACAAI) o 85 W. Algonquin Road, Suite 550, Arlington Heights, IL 60005

Release Date: November 12, 1999
Contact: Jo Ann Faber (847) 427-1200

Investigators Discover Potential Indicator for Chronic Fatigue Syndrome

CHICAGO, ILL. - The discovery of a potential indicator for chronic fatigue syndrome is among new findings presented at the American College of Allergy, Asthma and Immunology's (ACAAI) Annual Meeting in Chicago.
Chronic fatigue syndrome (CFS) is a debilitating disorder that causes unexplainable tiredness or lack of energy. It affects more than 14 million Americans, occurring mainly in adults aged 20 to 40 years and in twice as many women as men.

"Currently, the diagnosis of CFS involves a lengthy procedure of eliminating other possible causes of severe fatigue lasting more than six consecutive months," said ACAAI Past President Joseph A. Bellanti, M.D., of Georgetown University Medical Center in Washington, D.C. "Hopefully this data will provide a predictive marker of CFS which will help unravel the diagnosis and treatment of this perplexing disorder."

Investigators used data from a double blind placebo controlled study published February 1999, in the ACAAI'S scientific journal, "Annals of Allergy, Asthma and Immunology." The study reported subjects taking a nutritional supplement ENADA® - a stabilized oral absorbable form of nicotinamide adenine dinucleotide (NADH) - were four times more likely to show an improvement in CFS symptoms than those taking a placebo.

According to Dr. Bellanti, the follow-up study testing urinary concentrations in 20 of the CFS patients found that 75 percent showed elevated levels of a major breakdown product of serotonin, known as 5-HIAA. When treated with NADH, 70 percent of the patients returned to normal range, whereas in the placebo subjects, 70 percent retained elevated or increasing levels.

"The results of this study suggest that the measurement of urinary 5-HIAA may not only serve as a useful predictive marker of disease activity in CFS patients, but also may provide an objective measure of improvement following therapy with NADH," said Dr. Bellanti.

The Centers for Disease Control and Prevention (CDC) defined criteria for the diagnosis of chronic fatigue syndrome. Unexplained, debilitating fatigue of at least six month duration must be present, along with four or more of the following symptoms: neurocognitive dysfunction, muscle pain, sore throats, headaches, feeling of being sick or of physical discomfort after exertion, joint pain, sleep disturbances, or swelling and tenderness of lymph nodes.

For assistance in locating an allergist-immunologist, call the ACAAI toll-free number (800) 842-7777 or visit its public web site at http://allergy.mcg.edu.

The ACAAI is a professional medical organization comprised of 4,100 qualified allergists-immunologists and related health care professionals. The College is dedicated to the clinical practice of allergy, asthma and immunology through education and research to promote the highest quality of patient care.

Full-text articles published in "Annals of Allergy, Asthma & Immunology" are available free to media on the Internet at www.annallergy.org through December 2000. Thereafter, access will be limited to subscriptions.

FOR IMMEDIATE RELEASE:
Contact: Prof. Birkmayer Health Products USANovember 12, 1999 Bill Armstrong
New York, NY 1.760.438 2755

^ TOP

New Diagnostic Tool
for Chronic Fatigue Syndrome (CFS)
Presented to Annual Meeting of American College of Allergy,
Asthma and Immunology

CHICAGO, IL, Nov. 12, 1999, New data presented to the Annual Meeting of the American College of Allergy, Asthma and Immunology suggests the discovery of a potential diagnostic tool and therapeutic measurement for CFS.
The Centers for Disease Control and Prevention, report that chronic fatigue symptoms affect more than 14 million people between the ages of 17-69 and in twice as many women as men. "Currently, the diagnosis of CFS involves a lengthy procedure of eliminating other possible causes of severe fatigue lasting more than six consecutive months," said Dr. Joseph Bellanti, M.D., and Director of the International Center for Interdisciplinary Studies of Immunology at Georgetown University Medical Center, who identified a simple-to-test for urinary marker in CFS patients.

Last month a study published in the American Medical Association's The Archives of Internal Medicine reported that the incidence of CFS is significantly more prevalent than previous data suggests. The study reported women are 20 times more likely to develop CFS than breast cancer and more than 15 times more likely to contract CFS than lung cancer.
CFS patients suffer a debilitating illness that drastically affects their ability to work and live normal lives. CFS patients are often unable to complete the simplest of tasks without being exhausted. "Dr. Bellanti's work may represent a major breakthrough that will help doctors provide earlier diagnosis and better treatment," said Dr. Georg Birkmayer, M.D., Ph.D., the researcher who first discovered the therapeutic application of NADH in cellular development and energy transmission. NADH is a naturally occurring coenzyme that activates bodily energy production.

The Georgetown University Medical Center doctors' groundbreaking CFS research involved the use of ENADA® NADH a dietary supplement. Results of a double-blind, placebo-controlled cross-over study published in the February 1999 issue of Annals of Allergy, Asthma and Immunology found that CFS patients taking ENADA, a dietary supplement, were four times more likely to show improvements compare to those taking a placebo. A follow-up open label study showed 72% of the patients taking ENADA achieved continued marked improvement over time. After more than 18 months of using ENADA more than 80% of the CFS patients continue to experience improvement in their condition.

Dr. Bellanti's current study evaluated 20 of the original CFS test subjects and found that 75 percent showed elevated levels of a major breakdown metabolite product of serotonin, 5-HIAA which appears in urine. When treated with NADH, 70 percent of the patients returned to the normal range. In subjects taking a placebo, 70 percent retained elevated or increased levels of 5-HIAA.

Dr. Bellanti is founder and director of Georgetown University Medical Center's International Center for Interdisciplinary Studies of Immunology. He is a professor of pediatrics and microbiology. Dr. Bellanti has served on the Maternal and Child health Study Section of the National institutes of Child Health and Human Development (NICHD) and the Allergy and Immunology Research Committee of the National Institute of Allergy and Infectious Diseases NIAID). He has published more than 400 scientific papers, abstracts and books. He is the author of the widely renowned textbook on immunology, now in its third edition.
Prof. Birkmayer Health Products USA's mission is to develop and market safe, reliable and effective nutritional supplement products, which are designed to improve the quality of life for all people. Prof. Birkmayer Health Products USA's ENADA is the only patented, stabilized, absorbable, oral form of NADH. ENADA is the result of a decade of research and extensive toxicology and safety studies, culminating in the filing and issuing of an Investigational New Drug application (IND). The IND, issued in 1996, is number 49,635. The original code name of ENADA was Birmadil.

^ TOP

ENADA - A Nutritional Supplement for Healthy Individuals Desiring More Natural Energy

A Clinical Trial Reports Proven Energy Enhancement Using Strict FDA Testing Guidelines to Alleviate Symptoms of Chronic Fatigue Syndrome

WASHINGTON, DC, (February 23, 1999) - - Menuco Corporation announced today that ENADA®, a natural energy-enhancing nutritional supplement, tested by researchers at Georgetown University Medical Center, has achieved significant improvement in relieving the symptoms of people suffering from Chronic Fatigue Syndrome (CFS). CFS is a debilitating disorder caused by unexplainable tiredness or lack of energy, and has no known cure. According to the Centers for Disease Control, over 14 million people in the U.S. experience chronic fatigue symptoms. The Georgetown clinical trials focused on people diagnosed with CFS; however, ENADA is also a nutritional supplement for healthy individuals who desire additional energy.

ENADA is one of the first nutritional supplements to be tested using strict guidelines to determine its safety and effectiveness. Georgetown doctors found that 31% of the patients who took ENADA achieved significant improvement in the relief of their symptoms. In a follow-up study, 72% of the patients achieved positive results over a longer period of time. The double-blind, placebo-controlled human clinical trial results have recently been published in a prominent medical peer-reviewed journal called "Annals of Allergy, Asthma and Immunology." The findings of these clinical trials are being presented at the February 23, 1999 press conference at Georgetown University Medical Center.
"Eighty percent of Americans state that fatigue is their number one health complaint. We to demonstrate through sound scientific studies, not marketing hype, that ENADA is both safe and effective in providing energy enhancement to alleviate the symptoms of CFS, a debilitating disorder which affects half a million Americans," said Matt Fitzsimmons, president, Menuco Corporation. "Dr. Bellanti and his research colleagues at Georgetown University Medical Center have successfully demonstrated ENADA's effectiveness in increasing energy," says Fitzsimmons.

For years, research scientists have known that NADH a natural coenzyme plays an important role in the body's cellular energy producing function. NADH occurs naturally in the muscle tissue of fish, poultry and cattle - key food sources in the human diet. However, the human body absorbs miniscule amounts of NADH ingested from food sources. Also it is known that the more NADH a cell has, the more energy it can produce; therefore, the more energy a person has.

In 1996, ENADA received an Investigative New Drug (IND) acceptance allowing ENADA to begin a human double-blind, placebo-controlled, crossover study following strict pharmaceutical and drug testing guidelines. The study was conducted at the prestigious Georgetown University Medical Center in Washington, DC. (The IND number is 49,635 and the original working name of the product was Birmadil.)

Co-E1 NADH, ENADA NADH, CoQ10, ENADAlert

ts ability to be absorbed by the body quickly. Always consult a physician for guidance on any medical condition or medical treatment.

Please note when reading this report that co-e1 nadh, & co-e1 enada 5mg is the same product. & Enadalert is now known as 10mg & 20mg nadh also known as co-e1 nadh 10mg, c0-e1 enada. and 20mg is known as co-e1 energy pill and mojo enada.

click here for full pdf reports of nadh

PDF File on nadh

nadh information Newspaper report

more nadh Newpaper report on cancer research information

cancer research information

Attention Deficit Hyperactivity disorder Adhd

Alzheimers disease october 2002

Attention Deficit Hyperactivity Disorder.pdf

bloodpressure.pdf

Brain Abstract Altern Med Journal Dec 2005.pdf

BrainResearch Prevent Nitrationof Tyrosine Hydroxylase by Peroxynitrate Nov2001.pdf

Chronic Fatique Study 1999 2002 .pdf

Cornell University Cognitive Performance Study Oct 2001.pdf

Effects of Extracellular NADH on Human Tumor Cell Proliferation 1999.pdf

ENADA NADH improves cognitive impairment of Alzheimer patients ICMAN Proceedings Oct.2002.pdf

Enadalert Enhance Intracellular Energy Levels in Trained Athletes 2003.pdf

Fourth International AACFS Research Chronic Fatigue Syndrome 1998.pdf

ICMAN Nov 2002 Study on Alzheimers.pdf

In vitro antioxidative properties of reduced nicotinamide adenin dinucleotide Feb 2003.pdf